Newsbenzinga
Sonoma Pharmaceuticals Turns EBITDA Positive for First Time with Record Quarterly Revenue
· Published
Article summary
Sonoma Pharmaceuticals reported record Q1 revenue, narrow loss, doubled U.S. sales and achieved positive adjusted EBITDA for the first time.
An excerpt from the original article.
Comments —
Loading comments…